Olmesartan medoxomil

Drug ingredient

CAS 144689-63-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 144689-63-4
US productionNot reported
Import value, 2024$6.4B
Top sourceSingapore 36%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293499 · basket

These shares come from HS customs code 293499, which covers 575 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
SG 36%SingaporeIE 23%IrelandCN 11%ChinaCH 6%SwitzerlandIN 5%India
52 FDA-registered drug labelers
A-S Medication Solutions
Accord Healthcare Inc.
Ajanta Pharma USA Inc.
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Amneal Pharmaceuticals NY LLC
Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
Ascend Laboratories, LLC
Aurobindo Pharma Limited
AvKARE
Bryant Ranch Prepack
Cadila Pharmaceuticals Limited
Camber Pharmaceuticals, Inc.
Catalent Micron Technologies, Inc.
Chartwell RX, LLC
Chieron Active Ingredients Private Limited
Cosette Pharmaceuticals, Inc.
CTX Lifesciences Pvt. Ltd.
Direct_Rx
Divi's Laboratories Limited
EUROAPI Hungary Ltd.
Glenmark Pharmaceuticals Inc., USA
Golden State Medical Supply, Inc.
Granules India Limited
Hetero Labs Limited
Inventia Healthcare Limited
Jubilant Biosys limited
Jubilant Cadista Pharmacuticals Inc.
Lannett Company, Inc.
Lifestar Pharma LLC
Macleods Pharmaceuticals Limited
Matrix Pharmacorp Private Limited
Micro Labs Limited
Modavar Pharmaceuticals LLC
MSN Laboratories Private Limited
NorthStar RxLLC
Novadoz Pharmaceuticals LLC
Par Health USA, LLC
Proficient Rx LP
QUALLENT PHARMACEUTICALS HEALTH LLC
REMEDYREPACK INC.
Rising Pharma Holdings, Inc.
ScieGen Pharmaceuticals, Inc
Slate Run Pharmaceuticals, LLC
Solco Healthcare US, LLC
Teva API India Private Ltd
Teva Pharmaceuticals USA, Inc.
Viyash Life Sciences Private Limited
YiChang HEC ChangJiang Pharmaceutical Co.,Ltd.
Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
Zydus Lifesciences Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 13 drug and cosmetic product listings (FDA).

  • •olmesartan medoxomil
  • •Olmesartan Medoxomil and Hydrochlorothiazide
  • •Benicar HCT
  • •Azor
  • •Benicar
  • •Amlodipine and Olmesartan medoxomil
  • •Olmesartan medoxomil Amlodipine and Hydrochlorothiazide
  • •amlodipine besylate and olmesartan medoxomil
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

    Shortage listed since June 13, 2025

See all current drug shortages

Vendor Pricing

$5.24/gBLD Pharmatech Co., Limited
CountryUnited States
Pack$524.00 / 100 g
Purity98%
Vendors9 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

Chemical Identity

CAS144689-63-4
PubChem CID130881
DTXSIDDTXSID9045924
FormulaC29H30N6O6
Mol. Weight558.6 g/mol
SMILESCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O

Data Sources

Brief citations

Olmesartan medoxomil (CAS 144689-63-4) https://chemicalindependence.com/chemical/144689-63-4/ PubChem: 130881. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/130881 FDA National Drug Code directory: CAS 144689-63-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 144689-63-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293499 for CAS 144689-63-4. Reporting year: 2024. https://usatrade.census.gov/